Valiant Laboratories Ltd
₹57.28
(-3.08%)
Sun, 01 Mar 2026, 11:39 am
Valiant Laboratories Enterprise Value (EV)
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 1730 | 0 |
| Price to book ratio | 0 | 0 | 0 | 2.67 | 1.42 |
| Price to sales ratio | 0 | 0 | 0 | 3.04 | 2.50 |
| Price to cash flow ratio | 0 | 0 | 0 | 306.13 | 254 |
| Enterprise value | 0 | 0 | 0 | 4.86B | 3.79B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.01 | 0.86 | 0.60 | 0.32 | 0.52 |
| Return on equity % | 0 | 34.36 | 33.73 | 0.19 | -0.93 |
Valiant Laboratories Ltd Enterprise Value
The Valiant Laboratories Ltd Enterprise Value is a key financial metric used by investors to evaluate Valiant Laboratories Ltd's valuation, profitability, and overall financial performance. Tracking the Valiant Laboratories Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Valiant Laboratories Ltd (NSE: VALIANTLAB, BSE: 543998) is currently trading at ₹57.28, with a market capitalization of ₹3.09B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Valiant Laboratories Ltd Enterprise Value is essential for fundamental analysis.
Valiant Laboratories Ltd Enterprise Value Current Value
The current Valiant Laboratories Ltd Enterprise Value stands at 3.79B.
The Valiant Laboratories Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Valiant Laboratories Ltd Enterprise Value Historical Trend
The Valiant Laboratories Ltd Enterprise Value has shown the following historical trend:
- 2024: 3.79B
- 2023: 4.86B
- 2022: 0
- 2021: 0
- 2020: 0
The decline in Valiant Laboratories Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Valiant Laboratories Ltd Enterprise Value Indicates for Investors
The Valiant Laboratories Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Valiant Laboratories Ltd.
Valiant Laboratories Ltd Enterprise Value Analysis Summary
The Valiant Laboratories Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Valiant Laboratories Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Valiant Laboratories Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800